/주식/STIM
STIM

STIM

USD

Neuronetics Inc. Common Stock

$2.870+0.490 (20.588%)

실시간 가격

Healthcare
의료 기기
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$2.380

고가

$3.090

저가

$2.380

거래량

0.12M

기업 기본 정보

시가총액

189.8M

산업

의료 기기

국가

United States

거래 통계

평균 거래량

1.33M

거래소

NGM

통화

USD

52주 범위

저가 $0.52현재가 $2.870고가 $5.92

관련 뉴스

GlobeNewswire

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

Delivered $37.3 million total revenue in Q3 2025, representing 11% adjusted pro forma revenue growth versus Q3 2024 Generated Greenbrook clinic revenue of $21.8 million in Q3 2025, an increase of 25% on an adjusted

더 보기
Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan
GlobeNewswire

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve the quality of life

더 보기
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

MALVERN, Pa., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

더 보기
Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
GlobeNewswire

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who

더 보기
Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call